CLÍNICA BAVIERA, S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.8 EUR | +0.70% |
|
+0.70% | +25.22% |
| Feb. 29 | Clínica Baviera, S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 2023 | Clínica Baviera, S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023 | CI |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
| Sales 2022 | 198M 215M | Sales 2023 | 227M 246M | Capitalization | 375M 406M |
|---|---|---|---|---|---|
| Net income 2022 | 29M 31.39M | Net income 2023 | 36M 38.97M | EV / Sales 2022 | 1.48 x |
| Net Debt 2022 | 9.31M 10.08M | Net cash position 2023 | 2.49M 2.7M | EV / Sales 2023 | 1.64 x |
| P/E ratio 2022 |
9.64
x | P/E ratio 2023 |
10.4
x | Employees | 1,254 |
| Yield 2022 |
7.45% | Yield 2023 |
6.83% | Free-Float | 8.3% |
More Fundamentals
* Assessed data
More news
More press releases
More news
| Current month | +1.06% | ||
| 1 month | -0.69% | ||
| 3 months | +19.17% | ||
| 6 months | +42.29% | ||
| Current year | +24.35% |
1 week
28.00
28.60
1 month
27.9029.00
Current year
22.7029.30
1 year
17.3029.30
3 years
12.8029.30
5 years
8.0029.30
10 years
4.4029.30
| Managers | Title | Age | Since |
|---|---|---|---|
| Founder | 57 | 92-02-04 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 62 | 20-10-20 | |
| Founder | 57 | 92-02-04 | |
Bang Chen
CHM | Chairman | 59 | 17-08-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-15 | 28.8 | +0.70% | 1 749 |
| 24-05-14 | 28.6 | 0.00% | 65 |
| 24-05-13 | 28.6 | +0.35% | 644 |
| 24-05-10 | 28.5 | +0.71% | 1,680 |
| 24-05-09 | 28.3 | -1.05% | 1,223 |
Delayed Quote BME, May 14, 2024 at 11:35 am EDT
More quotes
Clinica Baviera SA is a Spain-based company engaged in the healthcare sector. The Company focuses on providing services within the field of ophthalmic medicine. The Company is specialized in the diagnosis and treatment of eye disorders, including myopia, hyperopia, astigmatism, cataracts, glaucoma, vitreous-retina and strabismus, among others. The Company operates a network of clinics located in various European countries, such as Spain, Germany, Austria and Italy. In addition, the Company is a parent of the Baviera Group, a group that comprises a number of controlled entities, including Clinica Baviera Italia Srl, Clinica Baviera Mallorca SL, Care Vision Germany GmbH and Castellana de Intermediacion Sanitaria SL, among others. The main shareholder of the Company is Aier Eye International (Europe) Slu.
Calendar
2024-07-22
- Q2 2024 Earnings Release (Projected)
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +24.35% | 504M | |
| -18.90% | 16.5B | |
| +6.31% | 12.81B | |
| +3.98% | 11.7B | |
| +3.03% | 10.09B | |
| +30.17% | 8.75B | |
| -3.40% | 7.77B | |
| +7.69% | 6.42B | |
| +5.28% | 6.67B | |
| +47.29% | 4.54B |
- Stock Market
- Equities
- CBAV Stock
